| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $2.26 | - | - |
| Q2'25 | $2.63 | $1.54 | -41.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $117.8B | - | - |
| Q2'25 | - | $119.0B | - |
Market Data
JBS is currently trading at $11.91, giving JBS N.V. a market cap of 12.73B and a P/E ratio of 7.3. Today's range spans $11.61–$11.95, with shares opening at $11.86 and moving up $0.01 (0.1%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL).
Over the past year JBS has traded between $11.49 and $18.65 - the current price is +3.7% off the 52-week low and -36.1% from the high. 19 analysts cover the stock with a Buy consensus and a mean 12-month target of $19.13 (range $15.30–$21.72), implying upside of +60.6%.
Earnings estimate risk is at the forefront for JBS N.V. (JBS) - a large-cap Consumer Defensive name (12.73B market cap) showing a SELL (23/100) alongside neutral sentiment (-/100) often flags a period where consensus estimates are still catching down to what the market is already pricing in. Price: $11.91 (near 52-week lows in $11.49–$18.65). (P/E: 7.3) Active managers who track the technical-fundamental gap tend to position ahead of the revision, not after it.
When a large-cap Consumer Defensive name with 12.73B in capitalization prints a SELL signal (23/100) alongside neutral news sentiment (-/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $11.91 (near 52-week lows in the $11.49–$18.65 range), the structural support levels are where that sponsorship question gets answered.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).